Overview

Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
0
Participant gender:
All
Summary
Self-administration of propofol and opioid mixture by the patient him- or herself (patient-controlled sedation, PCS) could be successful alternative to the anesthesiologists-managed deep sedation during endoscopic retrograde cholangiopancreatography (ERCP). However, it is not known which opioid would be the most suitable for PCS. The aim of this double-blind study was to compare remifentanil and alfentanil in PCS during ERCP.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Helsinki University Central Hospital
Treatments:
Alfentanil
Propofol
Remifentanil
Criteria
Inclusion Criteria:

- elective ERCP patients

Exclusion Criteria:

- allergy to propofol or opioid analgesics, drug addiction, inability to co-operate, ASA
class greater than 3, or patient's refusal.